ASKA Pharmaceutical Co., Ltd. Stock Japan Exchange
Equities
4514
JP3541200006
Pharmaceuticals
Sales 2024 * | 63.28B 400M | Sales 2025 * | 64.65B 408M | Capitalization | 64.02B 404M |
---|---|---|---|---|---|
Net income 2024 * | 6.47B 40.82M | Net income 2025 * | 4.89B 30.9M | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | 16.35B 103M | Net cash position 2025 * | 20.83B 131M | EV / Sales 2025 * | 0.67 x |
P/E ratio 2024 * |
9.89
x | P/E ratio 2025 * |
13.1
x | Employees | 747 |
Yield 2024 * |
1.77% | Yield 2025 * |
2.12% | Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
President | 71 | 21-03-31 | |
Kiyohiko Tamura
ADM | Chief Administrative Officer | - | - |
Kunihiro Gunji
CMP | Compliance Officer | - | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 71 | 21-03-31 | |
Atsushi Maruo
BRD | Director/Board Member | 65 | 21-03-31 |
Director/Board Member | 75 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |